| |
|
|
|
|
|
|
|||
|
Blood, 1 August 2006, Vol. 108, No. 3, pp. 904-907. Prepublished online as a Blood First Edition Paper on March 30, 2006; DOI 10.1182/blood-2005-12-4885.
Submitted December 13, 2005
Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Harvard Medical School, Boston, MA, USA * Corresponding author; email: havraham{at}bidmc.harvard.edu.
Matk/CHK knockout mice were reported to show no apparent phenotypic abnormalities. This was thought to be due to the homologous kinase Csk that compensates for Matk/CHK. Here, we present the first evidence that the non-receptor tyrosine kinase, Matk/CHK, is an important modulator of immune cell signaling. We found that the frequency of primitive hematopoietic cells, the side population c-kit+ Lin- Sca-1+ (SPKLS) cells, in Matk/CHK-/- mice was increased 2.2-fold compared to the control mice. Moreover, Matk/CHK deficiency led to significantly higher Pre-B cell colony formation following IL-7 stimulation. Interestingly, when mice received the in-vivo antigen challenge of TNP-Ovalbumin followed by re-stimulation, the Matk/CHK-/- lymph node and spleen cells produced significantly lower IFN-
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||